SCHEMBL3513892

SCHEMBL3513892

Cc1cc(CCC(O)c2ccc(SC(F)(F)F)cc2)cc(C)c1OC(C)(C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 19/20 0.47
PPARA Q07869 18/20 0.47
PPARG P37231 15/20 0.47
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2027940 0.88 PPARA (0.52) PPARDPPARAPPARG
SCHEMBL3511782 0.85 PPARD (0.54) PPARDPPARAPPARG
SCHEMBL1934856 0.81 PPARA (0.49) PPARDPPARAPPARGFFAR1FFAR4
SCHEMBL2029604 0.79 PPARD (0.48) PPARDPPARAPPARG
SCHEMBL28931138 0.76 PPARA (0.41) PPARDPPARAPPARG
SCHEMBL2030587 0.76 PPARA (0.51) PPARDPPARAPPARG
SCHEMBL24656182 0.75 PPARG (0.36) PPARDPPARAPPARG
SCHEMBL2029585 0.74 PPARA (0.49) PPARDPPARAPPARG
SCHEMBL2027126 0.74 PPARA (0.49) PPARDPPARAPPARG
SCHEMBL30007652 0.74 PPARD (0.56) PPARDPPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046716-B1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2013-08-14 EP claimed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US claimed
EP-2046716-B1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2013-08-14 EP disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-8188148-B2 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof GENFIT (FR) 2012-05-29 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof GENFIT (FR) 2010-11-11 US disclosed
WO-2007147880-A1 SUBSTITUTED 1,3-DIPHENYLPROPANE DERIVATIVES, PREPARATIONS AND USES THEREOF GENFIT (FR) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286276-A1 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof DPP3, DPP8, DPP4 PPARD 9/4885PPARA 11/4885PPARG 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.